Eli Lilly leads incretins via Zepbound/Mounjaro, retatrutide at 28.7% loss, $50B R&D and US buildout, 2025 guidance, ...

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed ...

Wave Life Sciences' shares jump 183% as early INLIGHT data on weight-loss drug WVE-007 show notable visceral fat cuts and ...

An experimental medication was shown to help boost weight loss by up to 20%, a study found. Eloralintide, a once-weekly injectable manufactured by Eli Lilly in Indianapolis, led to "meaningful, ...

Researchers have found that a specific body profile—higher muscle mass combined with a lower visceral fat to muscle ratio—tracks with a younger brain age, according to a study being presented next ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse. A more ...

The 150-year-old drugmaker is the first company in health care to hit the milestone. By Rebecca Robbins Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, ...

Intracranial electroencephalography measured the brain activity of a patient with obesity and loss-of-control eating after taking tirzepatide (Zepbound), showing the medication suppressed brain ...

A low-fat vegan diet is associated with a significant reduction in greenhouse gas emissions (GHGE) and cumulative energy demand (CED) compared to the Standard American Diet, according to research by ...

Novo Nordisk on Monday lowered the direct-to-consumer prices of its weight loss drug Wegovy and diabetes treatment Ozempic in a challenge to Eli Lilly’s Zepbound after President Donald Trump announced ...

GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid. Part of a class of drugs known ...

Harvard economist Roland Fryer provides surprising insights on how you think about household chores. What do the ESPN sports network and the weight-loss drug Zepbound have in common? Middlemen are ...